QCM
KNSA icon

QRG Capital Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

QRG Capital Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-14,033
Closed -$262K – 1099
2024
Q2 		$262K Sell
14,033
-1,145
-8% -$21.5K ﹤0.01% 912
2024
Q1 		$299K Sell
15,178
-832
-5% -$16.2K ﹤0.01% 892
2023
Q4 		$281K Buy
16,010
+1,679
+12% +$27.6K ﹤0.01% 891
2023
Q3 		$249K Buy
+14,331
New +$241K ﹤0.01% 867

Other funds holding KNSA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

QRG Capital Management's KNSA Position: Q3 2024 in Review

QRG Capital Management sold out of Kiniksa Pharmaceuticals (KNSA) in Q3 2024, closing a stake of 14,033 shares — an estimated $262K sold.

QRG Capital Management first reported a position in KNSA in Q3 2023 and held it in 4 quarters. The position peaked at $299K in Q1 2024. 176 funds tracked by Wall St. Rank hold KNSA as of Q3 2024.

  • QRG Capital Management reported no remaining Kiniksa Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • QRG Capital Management sold 14,033 Kiniksa Pharmaceuticals shares in Q3 2024, an estimated $262K.
  • QRG Capital Management first reported a position in Kiniksa Pharmaceuticals in Q3 2023 and held it in 4 quarters.
  • QRG Capital Management's Kiniksa Pharmaceuticals position peaked at $299K in Q1 2024.
  • 176 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q3 2024.

Based on QRG Capital Management's 13F filing for Q3 2024, filed 30 Oct 2024.